Active Biotech AB (ACTI) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.169x

Based on the latest financial reports, Active Biotech AB (ACTI) has a cash flow conversion efficiency ratio of -0.169x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-8.00 Million ≈ $-860.93K USD) by net assets (Skr47.20 Million ≈ $5.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ACTI market cap for the company's overall valuation and market capitalisation.

Active Biotech AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Active Biotech AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Active Biotech AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Active Biotech AB ranked by their cash flow conversion efficiency. Explore ACTI cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ICH Co Ltd KQ:368600	-0.014x
Vaishali Pharma Limited NSE:VAISHALI	0.030x
Cannabist Company Holdings Inc NEO:CBST	0.161x
Gratifii Ltd AU:GTI	0.129x
Putprop Ltd JSE:PPR	0.025x
Sri Adhikari Brothers Television Network Limited NSE:SABTNL	-36.713x
Kintavar Exploration Inc V:KTR	-0.021x
VR Resources Ltd V:VRR	-0.111x

Annual Cash Flow Conversion Efficiency for Active Biotech AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Active Biotech AB from 2002 to 2025. View ACTI share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr55.60 Million ≈ $5.98 Million	Skr-32.40 Million ≈ $-3.49 Million	-0.583x	+53.74%
2024-12-31	Skr32.07 Million ≈ $3.45 Million	Skr-40.40 Million ≈ $-4.35 Million	-1.260x	+15.54%
2023-12-31	Skr30.67 Million ≈ $3.30 Million	Skr-45.74 Million ≈ $-4.92 Million	-1.492x	+6.15%
2022-12-31	Skr34.51 Million ≈ $3.71 Million	Skr-54.85 Million ≈ $-5.90 Million	-1.589x	-60.68%
2021-12-31	Skr46.67 Million ≈ $5.02 Million	Skr-46.17 Million ≈ $-4.97 Million	-0.989x	+32.11%
2020-12-31	Skr22.11 Million ≈ $2.38 Million	Skr-32.22 Million ≈ $-3.47 Million	-1.457x	-118.79%
2019-12-31	Skr53.78 Million ≈ $5.79 Million	Skr-35.81 Million ≈ $-3.85 Million	-0.666x	-44.02%
2018-12-31	Skr87.92 Million ≈ $9.46 Million	Skr-40.65 Million ≈ $-4.37 Million	-0.462x	+22.68%
2017-12-31	Skr77.68 Million ≈ $8.36 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.598x	-49.20%
2016-12-31	Skr182.56 Million ≈ $19.65 Million	Skr-73.16 Million ≈ $-7.87 Million	-0.401x	+66.78%
2015-12-31	Skr180.60 Million ≈ $19.44 Million	Skr-217.89 Million ≈ $-23.45 Million	-1.206x	-83.08%
2014-12-31	Skr405.31 Million ≈ $43.62 Million	Skr-267.09 Million ≈ $-28.74 Million	-0.659x	-161.28%
2013-12-31	Skr405.41 Million ≈ $43.63 Million	Skr-102.25 Million ≈ $-11.00 Million	-0.252x	+64.34%
2012-12-31	Skr339.92 Million ≈ $36.58 Million	Skr-240.40 Million ≈ $-25.87 Million	-0.707x	-655.82%
2011-12-31	Skr501.99 Million ≈ $54.02 Million	Skr-46.97 Million ≈ $-5.05 Million	-0.094x	+91.34%
2010-12-31	Skr181.76 Million ≈ $19.56 Million	Skr-196.32 Million ≈ $-21.13 Million	-1.080x	+9.35%
2009-12-31	Skr188.64 Million ≈ $20.30 Million	Skr-224.77 Million ≈ $-24.19 Million	-1.192x	-22.25%
2008-12-31	Skr163.61 Million ≈ $17.61 Million	Skr-159.46 Million ≈ $-17.16 Million	-0.975x	+1.04%
2007-12-31	Skr189.57 Million ≈ $20.40 Million	Skr-186.70 Million ≈ $-20.09 Million	-0.985x	+40.63%
2006-12-31	Skr60.36 Million ≈ $6.50 Million	Skr-100.13 Million ≈ $-10.78 Million	-1.659x	-52.37%
2005-12-31	Skr176.81 Million ≈ $19.03 Million	Skr-192.51 Million ≈ $-20.72 Million	-1.089x	-18.08%
2004-12-31	Skr162.30 Million ≈ $17.47 Million	Skr-149.65 Million ≈ $-16.10 Million	-0.922x	+7.56%
2003-12-31	Skr289.58 Million ≈ $31.16 Million	Skr-288.83 Million ≈ $-31.08 Million	-0.997x	-30.02%
2002-12-31	Skr380.27 Million ≈ $40.92 Million	Skr-291.71 Million ≈ $-31.39 Million	-0.767x	--

About Active Biotech AB

ST:ACTI Sweden Biotechnology

Market Cap

$12.40 Million

Skr115.20 Million SEK

Market Cap Rank

#26591 Global

#559 in Sweden

Share Price

Skr4.37

Change (1 day)

+4.05%

52-Week Range

Skr0.04 - Skr7.20

All Time High

Skr28.53